510(k) Report

510(k) · Cleared

Cleared

Neurodyn Multiwave, Aussie Sport

K131629510(k) TraditionalCleared Nov 26, 2013175-day reviewClass II21 CFR 890.5850

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Ibramed Equipamentos Medicos · IPF Stimulator, Muscle, Powered

Cleared on Nov 26, 2013 as substantially equivalent to K121369 (Ibramed Equipamentos Medicos, 2012) and 2 other predicates after a 175-day review. Its family tree reaches back 2 generations to 1993. 1 later device descends from it.

Decided
Nov 26, 2013
Review
175 days
Class
Class II
Product code
IPF
Recalls
None
Predicates
3

Its longest line of descent runs back 2 generations to K931781 (1993). 6 ancestors in all. 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2012: 1 other ancestor2003: 1 other ancestor2000: 1 other ancestor1996: 1 other ancestor2021: 1 descendant clearedK931781 · Jace Tri-Stim Device · Jace Systems, Inc. · 1993K021100 · 300 PV Complete Electrotherapy System · Empi · 20021990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 2 other ancestors2 generations back: 2 other ancestors 1 generation forward: 1 descendant K021100 · 300 PV Complete Electrotherapy System · Empi · 2002K931781 · Jace Tri-Stim Device · Jace Systems, Inc. · 19930
  1. Root · 2 generations backK931781 Jace Tri-Stim DeviceJace Systems, Inc. · 1993
  2. 1 generation backK021100 300 PV Complete Electrotherapy SystemEmpi · 2002
  3. This deviceK131629 Neurodyn Multiwave, Aussie SportIbramed Equipamentos Medicos · 2013
  4. Descendant · cites it directly · 0 of its ownK210572 Neurodyn V2.0, Neurodyn Aussie V2.0Ibramed Equipamentos Medicos · 2021

Most influential descendants

Showing 1 of 1 · See all
  • K210572Neurodyn V2.0, Neurodyn Aussie V2.0Ibramed Equipamentos Medicos · 2021 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K931781Jace Tri-Stim DeviceJace Systems, Inc.1993—
−1K021100300 PV Complete Electrotherapy SystemEmpi2002—
0 (this device)K131629Neurodyn Multiwave, Aussie SportIbramed Equipamentos Medicos2013—
+1K210572Neurodyn V2.0, Neurodyn Aussie V2.0Ibramed Equipamentos Medicos2021—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199610
200010
200310
201210

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202110
FIG. 1 — Lineage of K131629, 1993–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in IPF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new IPF device

  1. #1 K241433 EVE Synergy (EVE-20M)score 19.7 · 25 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K121369Neurodyn Ruby Muscle Stimulator, Neurodyn Aussie Muscle Stimulator
Summary page 1
…scle stimulator LIH - Interferential Current Thera py-Pre-amend ment GZI- 21 CER 882.5890 -External functional neuromuscular stimulator Predicate Device Identification: K121369 Neurodyn/Neurodyn Aussie Powered Muscle Stimulator K021100 300 PV Complete Electrotherapy K031077 Vectra Genisys Predicate devic…
Ibramed Equipamentos Medicos2012—
*K021100300 PV Complete Electrotherapy System
Summary page 1
…mend ment GZI- 21 CER 882.5890 -External functional neuromuscular stimulator Predicate Device Identification: K121369 Neurodyn/Neurodyn Aussie Powered Muscle Stimulator K021100 300 PV Complete Electrotherapy K031077 Vectra Genisys Predicate devices had been submitted and cleared by 510(k) for the same in…
Empi2002—
*K031077Vectra Epr System and Intelect Epr System
Summary page 1
…l functional neuromuscular stimulator Predicate Device Identification: K121369 Neurodyn/Neurodyn Aussie Powered Muscle Stimulator K021100 300 PV Complete Electrotherapy K031077 Vectra Genisys Predicate devices had been submitted and cleared by 510(k) for the same intended uses and IBRAMVE…
Chattanooga Group200317

Also cleared against K121369: 2 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K210572Neurodyn V2.0, Neurodyn Aussie V2.0Ibramed Equipamentos Medicos20210

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 20 years and passes through 3 companies; a new generation was cleared every 11.4 years on median.
  • 1 of the 6 ancestors has a recall of any class.
  • Of its descendants, K210572 (Ibramed Equipamentos Medicos, 2021) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K121369.

How does its category compare?

All IPF devices

IPF Stimulator, Muscle, Powered: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.

FDA decisions per year · IPF

3in 2025

2007: 82008: 62009: 72010: 42011: 42012: 42013: 102014: 42015: 32016: 72017: 52018: 52019: 42020: 92021: 152022: 72023: 92024: 72025: 32026 (partial year): 3
2007high 15 (2021) · low 3 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · IPF

257in 2025

2007: 143 days median2008: 140 days median2009: 216 days median2010: 121 days median2011: 275 days median2012: 269 days median2013: 180 days median2014: 264 days median2015: 43 days median2016: 113 days median2017: 110 days median2018: 73 days median2019: 133 days median2020: 121 days median2021: 98 days median2022: 108 days median2023: 255 days median2024: 201 days median2025: 257 days median2026 (partial year): 206 days median
2007high 275 (2011) · low 43 (2015)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · IPF

1in 2023

2008: 12011: 12012: 32023: 1
2007high 3 (2012) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · IPF

8in 2025

2007: 112008: 2132009: 1502010: 142011: 252012: 162013: 62014: 192015: 112016: 82017: 22018: 32019: 102020: 132021: 32022: 42023: 82024: 52025: 8
2007high 213 (2008) · low 2 (2017)2025

MAUDE reports naming product code IPF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20078143011
200861401213
200972160150
20104121014
20114275125
20124269316
20131018006
20144264019
2015343011
2016711308
2017511002
201857303
20194133010
20209121013
2021159803
2022710804
2023925518
2024720105
2025325708
202632060—

What is it indicated for?

Neurodyn Multiwave - Indications for Use: As a FES device: - Stimulation of the muscles in the leg and ankle of partially paralyzed patients to provide flexion of the foot and thus improve the patient's gait. As a TENS device: - Symptomatic relief of chronic (long term) intractable pain - Symptomatic relief of post-traumatic acute pain and post-surgical pain As an Interferential and Premodulated device: - Symptomatic relief of chronic intractable pain…

Read the full statement (268 words)

Neurodyn Multiwave - Indications for Use:

As a FES device:

- Stimulation of the muscles in the leg and ankle of partially paralyzed patients to provide flexion of the foot and thus improve the patient's gait.

As a TENS device:

- Symptomatic relief of chronic (long term) intractable pain

- Symptomatic relief of post-traumatic acute pain and post-surgical pain

As an Interferential and Premodulated device:

- Symptomatic relief of chronic intractable pain, acute post traumatic pain, or acute post traumatic surgical pain

As a Russian device:

- Temporary relaxation of muscle spasms

- Prevention or retardation of disuse atrophy in post-injury type conditions

- Increase local blood circulation

- Muscle re-education

- Maintaining or increasing range of motion

As a Burst Modulated Alternating Current (Aussie) device:

- Temporary relaxation of muscle spasms

- Prevention or retardation of disuse atrophy in post-injury type conditions

- Increase local blood circulation

- Muscle re-education

- Maintaining or increasing range of motion

- Symptomatic relief of chronic intractable pain, acute post traumatic pain, or acute post traumatic surgical pain

As a Microcurrent device:

- Symptomatic relief of chronic intractable pain

- Symptomatic relief of post-traumatic acute pain and post-surgical pain

As a DC/Polarized device:

- Relaxation of Muscle Spasm

Aussie Sport - Indications for Use:

As an Burst Modulated Alternating Current (Aussie) device:

- Temporary relaxation of muscle spasms

- Prevention or retardation of disuse atrophy in post-injury type conditions

- Increase local blood circulation

- Muscle re-education

- Maintaining or increasing range of motion

- Symptomatic relief of chronic intractable pain, acute post traumatic pain, or acute post traumatic surgical pain

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K131629: Neurodyn Multiwave, Aussie Sport.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K131629

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026